Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners

Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Sep 17, 2025 9:08:36 AM
3
min read
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
.png)
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
Oct 18, 2023 2:15:00 PM
2
min read
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft

Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
Jun 21, 2022 1:15:00 PM
2
min read